((自动化翻译由路透提供，请见免责声明 )) (更新)
10月24日 - ** 医疗设备制造商West Pharmaceutical Services 股价上涨17.12%，至335.47美元
** 公司上调了 (link)，预计全年每股收益介于6.55美元至6.75美元之间，而之前的预期区间 为6.35美元至6.65美元。
** 预计全年营收介于 28.8 亿美元至 29.1 亿美元之间，高于此前预期的 28.7 亿美元至 29.0 亿美元之间。
** 根据 LSEG 整理的数据，分析师平均预期全年每股利润为 6.51 美元，总收入为 28.7 亿美元。
** 公司称正接近 "去库存化趋势的转折点"，客户对增加近期订单量表现出兴趣
** 公布的第三季度副利润为每小时 1.85 美元，而分析师预计为每小时 1.50 美元
** 截至上次收盘，股价累计下跌约 5
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.